Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 1Esophageal Neoplasms 1Cognitive Dysfunction 1

Interventions

Memantine 2acetaminophen, aspirin, caffeine drug combination 1Transcranial Direct Current Stimulation 1Time 1Sugars 1Sirolimus 1Riluzole 1Referral and Consultation 1Ramipril 1Radiotherapy, Intensity-Modulated 1Palliative Care 1Ibuprofen 1Exercise 1Donepezil 1Cognitive Behavioral Therapy 1Cannabidiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Cognitive Dysfunction × Time × Clear all
NCT04669301 2025-07-15

Memory and Attention Adaptation Training-Geriatrics (MAAT-G) Phase II

University of Rochester

Phase NA Completed
72 enrolled 15 charts

Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡